Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia

ABSTRACT: To compare the effects of TAS-102 with placebo in patients with metastatic colorectal cancer refractory or intolerable to standard chemotherapies.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2152626 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR